Results show the regimen of epcoritamab plus R-ICE could serve most patients as a bridge to either autologous stem cell ...

Tabelecleucel shows promising efficacy in treating EBV-positive PTLD, offering hope for patients resistant to previous ...

Epkinly (epcoritamab) is a subcutaneously delivered CD3×CD20 BiTE that secured FDA accelerated approval in 2023 for r/r DLBCL.

The BM12 CAST trial, a major clinical trial led by the Australasian Leukaemia & Lymphoma Group (ALLG) across New Zealand and Australian hospitals, will transform global blood stem cell transplant ...

Last fall, the 29-year-old came to the Hospital of the University of Pennsylvania from his home in Switzerland for a rare ...

Rates of grade III/IV acute GVHD at 3 months were 3% with cyclophosphamide-cyclosporin prophylaxis and 10% with standard prophylaxis, reported David Curtis, MBBS, PhD, of Alfred H ...

Two posters presented at the 2025 European Hematology Association Congress support combination therapy with daratumumab, ...

A UK study suggests lower red blood cell transfusion thresholds may be safe for children after stem cell transplant, showing ...

A phase 3 trial did not support a transplant-based approach for patients who already achieved MRD negativity or a tandem ...

Clarks Summit resident Courtenay Degnon considers herself a typical mom of two teenagers. She works daily. She makes sure the ...

Meerut: A 15-year-old girl, who lost her right arm in an electrocution accident in 2022, underwent a successful shoulder-level limb transplant at Gleneagles Hospital in Mumbai. The surgery ...

A painter who lost both of his arms in a bike crash has undergone a successful double arm transplant. Raj Kumar underwent the 12-hour surgery on January 19 at Sir Ganga Ram Hospital in Delhi, India.